A. Brattström

1.3k total citations
55 papers, 989 citations indexed

About

A. Brattström is a scholar working on Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, A. Brattström has authored 55 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Complementary and alternative medicine, 13 papers in Cardiology and Cardiovascular Medicine and 11 papers in Endocrine and Autonomic Systems. Recurrent topics in A. Brattström's work include Medicinal Plant Extracts Effects (15 papers), Heart Rate Variability and Autonomic Control (11 papers) and Neuroscience of respiration and sleep (9 papers). A. Brattström is often cited by papers focused on Medicinal Plant Extracts Effects (15 papers), Heart Rate Variability and Autonomic Control (11 papers) and Neuroscience of respiration and sleep (9 papers). A. Brattström collaborates with scholars based in Germany, Switzerland and United States. A. Brattström's co-authors include Uwe Koetter, Ehab A. Abourashed, E. Schrader, Martina Trümmel, Stefan Peters, Stefka Stoyanova, Matthias Hamburger, Heiko Rust, Beat Meier and Axel Becker and has published in prestigious journals such as Cellular and Molecular Life Sciences, Life Sciences and Psychoneuroendocrinology.

In The Last Decade

A. Brattström

48 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Brattström Germany 17 325 249 209 194 129 55 989
Toshihiko Hanawa Japan 22 347 1.1× 142 0.6× 318 1.5× 407 2.1× 31 0.2× 133 1.5k
Rongjie Zhao South Korea 20 355 1.1× 96 0.4× 515 2.5× 255 1.3× 37 0.3× 54 1.4k
Huei-Yann Tsai Taiwan 15 334 1.0× 211 0.8× 407 1.9× 187 1.0× 28 0.2× 36 1.3k
H Woelk Germany 20 201 0.6× 166 0.7× 456 2.2× 48 0.2× 21 0.2× 54 1.3k
Masoumeh Emamghoreishi Iran 17 243 0.7× 203 0.8× 228 1.1× 74 0.4× 18 0.1× 56 1.0k
Aman Upaganlawar India 17 256 0.8× 173 0.7× 252 1.2× 93 0.5× 146 1.1× 50 1.0k
José Eduardo da Silva‐Santos Brazil 23 152 0.5× 315 1.3× 446 2.1× 159 0.8× 104 0.8× 60 1.4k
Gbola Olayiwola Nigeria 15 88 0.3× 175 0.7× 108 0.5× 90 0.5× 39 0.3× 46 642
Ayat Kaeidi Iran 21 89 0.3× 109 0.4× 240 1.1× 100 0.5× 15 0.1× 76 1.0k
Ki‐Ho Cho South Korea 19 660 2.0× 152 0.6× 513 2.5× 230 1.2× 65 0.5× 143 1.9k

Countries citing papers authored by A. Brattström

Since Specialization
Citations

This map shows the geographic impact of A. Brattström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brattström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brattström more than expected).

Fields of papers citing papers by A. Brattström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Brattström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brattström. The network helps show where A. Brattström may publish in the future.

Co-authorship network of co-authors of A. Brattström

This figure shows the co-authorship network connecting the top 25 collaborators of A. Brattström. A scholar is included among the top collaborators of A. Brattström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Brattström. A. Brattström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, Axel, et al.. (2014). The anxiolytic effects of a Valerian extract is based on Valerenic acid. BMC Complementary and Alternative Medicine. 14(1). 267–267. 48 indexed citations
2.
4.
Brattström, A., Andreas Schapowal, Isabelle Maillet, et al.. (2009). Petasites extract Ze 339 (PET) inhibits allergen‐induced Th2 responses, airway inflammation and airway hyperreactivity in mice. Phytotherapy Research. 24(5). 680–685. 14 indexed citations
5.
Bauer, Steffen, et al.. (2008). St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive. European Journal of Clinical Pharmacology. 65(3). 287–294. 29 indexed citations
6.
Brattström, A.. (2007). Scientific Evidence for a Fixed Extract Combination (Ze 91019) from Valerian and Hops traditionally used as a Sleep-inducing Aid. Wiener Medizinische Wochenschrift. 157(13-14). 367–370. 13 indexed citations
7.
Polasek, Wolfgang, et al.. (2006). Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: Postmarketing surveillance study. Advances in Therapy. 23(2). 373–384. 24 indexed citations
8.
Abourashed, Ehab A., Uwe Koetter, & A. Brattström. (2004). In vitro binding experiments with a Valerian, Hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine. 11(7-8). 633–638. 71 indexed citations
10.
Stoyanova, Stefka, et al.. (2001). Identification and Isolation of the Cyclooxygenase-2 Inhibitory Principle in Isatis tinctoria. Planta Medica. 67(5). 411–416. 109 indexed citations
12.
Brattström, A., et al.. (2001). Effizienter Einsatz von Schlafkissen bei Personen mit nicht-organischen Schlafstörungen – eine Pilotuntersuchung. Complementary Medicine Research. 8(5). 299–304. 1 indexed citations
13.
Brattström, A., et al.. (2000). Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study.. PubMed. 5(9). 385–90. 24 indexed citations
14.
Peters, Stefan, et al.. (2000). Familial hypertrophic cardiomyopathy associated with prolongation of the QT interval. Zeitschrift für Kardiologie. 89(7). 624–629. 6 indexed citations
15.
Berger, Dave K., W. Schaffner, E. Schrader, Beat H. Meier, & A. Brattström. (2000). Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Archives of Gynecology and Obstetrics. 264(3). 150–153. 67 indexed citations
16.
Brattström, A., et al.. (1993). Effects of central Substance P on baroreflex regulation. Neuropeptides. 25(1). 77–81. 4 indexed citations
17.
Brattström, A., et al.. (1992). Cardiovascular Responses to Centrally Applied Sodium Chloride Solution. Clinical and Experimental Hypertension Part A Theory and Practice. 14(6). 1051–1065. 3 indexed citations
18.
Brattström, A., Wybren de Jong, & D. de Wied. (1990). Central Vasopressin Impairs the Baroreceptor Heart Rate Reflex in Conscious Rats. Journal of Cardiovascular Pharmacology. 15(1). 114–117. 13 indexed citations
19.
Brattström, A., Wybren de Jong, J.P.H. Burbach, & D. de Wied. (1989). Vasopressin, vasopressin fragments and a C-terminal peptide of the vasopressin precursor share cardiovascular effects when microinjected into the nucleus tractus solitarii. Psychoneuroendocrinology. 14(6). 461–467. 8 indexed citations
20.
Brattström, A., Wybren de Jong, & D. de Wied. (1988). Vasopressin micro-injections into the nucleus tractus solitarii decrease heart rate and blood pressure in anaesthetized rats. Journal of Hypertension. 6(4). S521–524. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026